What is Mazdutide?

The short answer

Mazdutide is a lab-made peptide that copies two hormones, tested so far mostly outside the US.

  • What it is

    Activates GLP-1 and glucagon receptors.

  • What people look into

    Weight

Get updates on Mazdutide

What it is

Type
GLP-1/glucagon dual agonist (peptide)
Also known as
ibi362, ly3305677
How it works
Activates GLP-1 and glucagon receptors.

Regulatory status

Not FDA-approved How we label status

As of October 4, 2026, Mazdutide is not FDA-approved for any use and is not on FDA's 503A bulks list.

See Mazdutide in the Index →

Federal (FDA)
Not FDA-approved; no US phase 3 or filing (China trials)
503A compounding
No category; not on 216.23 as of 2026-10-07; not an approved-drug component (as of October 7, 2026)

US enforcement actions

4 US enforcement actions since 2024.

Actions by US federal and state agencies whose documents name Mazdutide. Each row links to the government's own document.

Scroll sideways to see all columns.

US enforcement actions table
DateAgencyActionDocument
FDAWarning letterFDA document, warning letter, August 24, 2026, on fda.gov
FDAWarning letterFDA document, warning letter, March 31, 2026, on fda.gov
FDAWarning letterFDA document, warning letter, December 10, 2024, 1 of 2 that day, on fda.gov
FDAWarning letterFDA document, warning letter, December 10, 2024, 2 of 2 that day, on fda.gov

References

Sources as of October 4, 2026

  1. FDA: www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  2. FDA: api.fda.gov/drug/drugsfda.json
  3. ClinicalTrials.gov: clinicaltrials.gov/study/NCT06184568
  4. eCFR: www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23